Healios KK (HLOSF)
0.9929
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Healios Free Cash Flow (Quarterly): -8.073M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.073M |
| September 30, 2023 | -3.575M |
| June 30, 2023 | -3.517M |
| March 31, 2023 | -5.148M |
| December 31, 2022 | -7.440M |
| September 30, 2022 | -8.568M |
| June 30, 2022 | -8.442M |
| March 31, 2022 | -12.84M |
| December 31, 2021 | -16.79M |
| September 30, 2021 | -10.38M |
| Date | Value |
|---|---|
| June 30, 2021 | -8.877M |
| March 31, 2021 | -13.07M |
| December 31, 2020 | -12.41M |
| September 30, 2020 | -8.853M |
| June 30, 2020 | -10.45M |
| March 31, 2020 | -8.182M |
| December 31, 2019 | -8.698M |
| September 30, 2019 | -12.09M |
| June 30, 2019 | -12.55M |
| March 31, 2019 | -12.40M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.79M
Minimum
Dec 2021
-3.517M
Maximum
Jun 2023
-9.472M
Average
-8.853M
Median
Sep 2020
Free Cash Flow (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 476.74M |
| Nxera Pharma Co Ltd | -9.318M |
| PeptiDream Inc | 21.30M |
| Stemcell Holdings Inc | -- |
| AnGes Inc | -- |